Anesthetic pharmacology /
Saved in:
Edition: | 2nd ed. |
---|---|
Imprint: | Cambridge ; New York : Cambridge University Press, c2011. |
Description: | xv, 1194 p. : ill. ; 29 cm. |
Language: | English |
Series: | Cambridge medicine Cambridge medicine (Series. |
Subject: | |
Format: | E-Resource Print Book |
URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/8455716 |
Table of Contents:
- Preface to the first edition
- Preface to the second edition
- Part I. Principles of Drug Action
- 1. Pharmacodynamic principles of drug action
- 2. G protein coupled receptors
- 3. Other signalling pathways
- 4. Signal transduction mechanisms: ion channels
- 5. Principles of pharmacokinetics
- 6. Principles of drug transformation
- 7. Drug transport and transporters
- 8. Target controlled infusions and closed loop administration
- 9. Alternate routes of drug administration
- 10. Principles of pharmacogenetics
- 11. Pharmacodynamic drug interactions in anesthetic practice
- 12. Pharmacoeconomics
- Part II. Physiologic Substrates of Drug Action
- 13. Sleep and consciousness
- 14. Synaptic transmission
- 15. Memory, learning and cognition
- 16. Mechanisms of pain transmission and transduction
- 17. Generation and propagation of action potentials
- 18. Neuromuscular junction
- 19. Vascular reactivity
- 20. Cardiac rhythm
- 21. Myocardial performance
- 22. Autonomic function
- 23. Physiology of immunity and inflammation
- Part III. Essential Drugs in Anesthetic Practice
- 24. Mechanisms of anesthetic action
- 25. Pharmacokinetics of inhaled anesthetics
- 26. Clinical pharmacology of inhaled anesthetics
- 27. Pharmacokinetics of intravenous anesthetics
- 28. Clinical pharmacology of intravenous anesthetics
- 29. Benzodiazepines
- 30. ¿-2 Agonists and other sedatives and amnestics
- 31. Mechanisms of action of opioids
- 32. Pharmacokinetics of opioids
- 33. Clinical pharmacology of opioids
- 34. Nonsteroidal anti-inflammatory drugs
- 35. Other ion channel and receptor ligands for analgesia
- 36. Local anesthetics
- 37. Anticonvulsant and antipsychotic drugs
- 38. Neuromuscular blocking agents
- 39. Reversal drugs
- 40. Sympathomimetics and vasoconstrictors
- 41. Parasympathomimetic and parasympatholytic drugs
- 42. ß-blockers and other adrenergic receptor antagonists
- 43. Antiarrhythmic agents
- 44. Positive inotropic drugs
- 45. Vasodilators (incl. ACE inhibitors and NO)
- 46. Calcium channel blockers
- 47. Bronchodilators
- 48. Pulmonary vasodilators
- 49. Drugs acting via the kidney
- 50. Fluids and electrolytes as pharmacologic agents
- 51. Corticosteroids and anti-inflammatory agents
- 52. Anti-rejection drugs and immunosuppressants
- 53. Antimotility and antisecretory agents
- 54. Antiemetics
- 55. Insulin and anti-hyperglycemic agents
- 56. Nutritional elements of management
- 57. Agents affecting coagulation and platelet function
- 58. Obstetrical adjuvants and obstetric pharmacology
- 59. Antimicrobial therapy
- Part IV. Clinical Application and Anesthesia Practice (Evidence Based, Rational Drug Selection, Management)
- 60. Pre-operative management
- 61. Induction of anesthesia
- 62. Maintenance and emergence from anesthesia
- 63. Management of sedation, analgesia and delirium
- 64. Post-operative analgesia
- 65. Control of blood pressure and vascular tone
- 66. Cardiac protection and pharmacologic management of myocardial ischemia
- 67. Management of patients with chronic alcohol or drug use
- 68. Drug allergy and treatment
- 69. Special populations - pediatric
- 70. Special populations - geriatric
- 71. Emerging concepts: neuroprotection and neurotoxicity
- Index